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Methylmercury is a neurotoxin that at high exposures can cause microcephaly, cerebral palsy, seizures, mental retardation, and death (12) . Several poisoning episodes have confirmed that the fetal brain is particularly susceptible to methylmercury. The most severe effects were seen in Minamata and Niigata, Japan (3) , where children were born with severe cerebral palsy in a population that consumed seafood contaminated with methylmercury from an industrial operation. Because exposure to methylmercury is primarily through the consumption of fish, concern has been raised regarding the health of children whose mothers consumed fish during pregnancy.
A reference dose (RfD) for methylmer- (7, 8) . The Seychelles study examined longitudinally the neurologic and psychologic responses of 708 children whose mothers consumed a relatively large amount of fish during pregnancy (7, 8) . The The BMD method has several advantages over the NOAEL method, including making better use of dose-response information and reflecting sample size more appropriately (9, 11) . When applied to epidemiologic data, the BMD allows for consideration of the dose response over the entire exposure range rather than assuming that the mean exposure is either a NOAEL or LOAEL.
Another advantage of the BMD method is that a BMDL can be calculated from negative data (data in which no statistically significant dose-related trend is present). With negative data, the point estimate of the dose-response trend may be positive (in the direction of an adverse effect), zero, or negative (in the direction of a beneficial effect), although any deviation from zero may reflect only random variation and not a real effect of exposure. If the point estimate of the trend is zero or negative, the point estimate of the BMD will be infinite (undefined), whereas if the point estimate of the trend is positive, the point estimate of the BMD will be finite. A statistical upper bound on the BMD obtained from negative data will be infinite; otherwise the data would, by definition, not be negative. However, a BMDL derived from negative data will be a finite number as long as the data do not demonstrate a statistically significant negative trend. When data are negative, it is possible that there is no effect of treatment, in which case a BMDL reflects only the statistical constraints imposed by the experimental design. However, a BMDL represents a conservative (in the health-protective sense) value. Even though the data were negative, exposure could have caused a small undetected increase in an adverse health effect. The BMDL is a statistical bound that reflects the potential size of such an increase.
We present benchmark analyses of the Seychelles data similar to those applied to the Iraqi data by the EPA in the development of the methylmercury RfD. These analyses may provide a sounder scientific basis for developing an RfD or MRL from the Seychelles data than a NOAEL estimated from this study. In addition to the Seychelles study, neurologic studies of children from high fish-consuming populations have also been conducted in New Zealand (13, 14) and the Faroe Islands (15) . These studies should also be considered when developing an exposure advisory for methylmercury. A benchmark analysis similar to ours from the Seychelles data has been developed from the New Zealand data (14) .
The Seychelles Study
The Seychelles Child Development Study (7, 8, 16, 17) began in 1989 in the Republic of Seychelles, an archipelago in the Indian Ocean, to measure developmental outcomes in children whose mothers consumed fish containing methylmercury during their pregnancy. More than 700 mother/infant pairs were enrolled in the main study during pregnancy. The children's prenatal mercury exposure was assessed by measuring the concentration of mercury in a segment of maternal hair representative of the hair formed during pregnancy. At 6.5 months of age, the children were given a neurologic examina tion, tests of visual recognition memory (18) and visual attention (19) , and the Denver Developmental Screening Test -Revised (20) . The Bayley Scales of Infant Development (21) were given at 19 months and again at 29 months. The ages at which a child first walked and first talked were also recorded. At (27) ], home environment [HOME (28)], parental education, and others shown in Table 1 .
Mercury hair concentrations in maternal hair ranged from 0.5 to 26.7 ppm, and averaged 6.8 ppm. By contrast, hair mercury concentrations in the U.S. are estimated to average 0.5 ppm (4) . No adverse outcomes were associated with mercury exposure at any age in the Seychelles study.
Benchmark Methodology
Most of the measured end points in the Seychelles study were recorded as continuous responses, and several dose-response models were applied to these continuous end points. In the k-power model (10) [2] where N is the standard normal cumulative distribution function. (10) . This is obvious from the equivalent definition of the BMD given by Equation 5 .
In addition to the k-power model, two other dose-response models were applied to continuous data from the Seychelles study. As [6] and one determined by the logistic model, [7] where P . 0 and K . 1 are estimated parameters that have roughly the same interpretation as the corresponding parameters in the k-power model. As in the k-power model, with these models, the BMD will be a function of the covariates when x0 is specified, but not when p0 is specified. Each of the three models for continuous data (k-power, Weibull, and logistic) was applied to the continuous responses from Seychelles data both with p0 specified and with x0 specified. In addition, a linear model was applied. The linear model was defined by fixing K = 1 in the k-power model. In analyses in which p0 was specified, it was fixed at 0.05, as suggested by the convention of considering 95% of clinical responses in healthy individuals to define the normal range. In analyses in which x0 was specified, it was fixed at 2 SDs (in the adverse direction) from the overall mean response.
For a few of the tests a child's response was recorded as a quantal response (e.g., abnormal/normal), and the results from these tests were modeled using the Weibull (Equation 6 ) dose-response model for quantal data. In addition, each of the continuous responses was converted into a quantal response by considering a response abnormal if it was more than 2 SDs away (in the adverse direction) from the mean response of the entire cohort, and then analyzed using the Weibull model. In these analyses the BMD was defined in the same way as in the analyses of the continuous responses, i.e., as the mercury hair concentration that corresponded to an increase in 0.1 in the probability of an abnormal response [Equation 4 with BMR = 0. 1].
We conducted each analysis of a continuous response without covariates. In addition, analyses with po specified were also conducted using both an expanded set and a reduced set of covariates (Table 1) . These sets of covariates have essentially the same definitions as those in the original analyses (7, 8, 16, 17) . In all models for continuous responses with p0 specified, the BMD, as well as corresponding point (10) .
Discussion
The point estimates of the BMDs (data not shown) were in many instances theoretically infinite because many of the dose-response trends, although nonsignificant, were in the direction of a beneficial effect of mercury. However, the BMDLs were all finite, and their values reflect the potential magnitude of any small effect of mercury that went undetected in this study.
BMDLs obtained from continuous data using the Weibull, logistic, and k-power models were similar. Application of the linear model resulted in larger BMDLs (data not shown) that were outside the range of maternal hair levels observed in the study. The inclusion of covariates had little effect on the BMDLs. Likewise, BMDLs were similar whether based on specification of the background response, p0, or of x0, the magnitude of a response considered abnormal. However, BMDLs based on quantal data were consistently smaller than those based on the corresponding continuous data. For example, the BMDLs computed from 12 quantal responses using the Weibull distribution (Table 4) Considering the analyses that were comparable to those in the present study (po = 0.05 and BMR = 0.1), the BMDLs obtained ranged from 54 to 152 ppm. This range was consistent with the conclusion by Crump et al. (32) based on other analyses of the Iraqi data that there was no conclusive evidence of a mercury effect in this study below a maternal hair level of 80 ppm. The maternal hair level used in the present study was the peak level during pregnancy, whereas the average level during pregnancy was used in the Seychelles and New Zealand studies. BMDLs from the Iraqi study would have been smaller if they had been based on the average level.
To derive its RfD from the Iraqi study, the EPA (4) defined an overall quantal measure of neurologic health defined in terms of whether a child was abnormal in any one of three outcomes (first walked after 18 months of age, first talked after 24 months of age, or had a score > 3 on a neurologic examination). This combined response was grouped into five dose groups according to the mothers' peak mercury hair concentration during pregnancy. A Weibull dose response applied to these grouped data resulted in a BMDL of 11 ppm mercury in mothers' hair. There are several potential reasons why this BMDL was lower than the range of 54 to 152 obtained by Crump et al. (32) . First, collapsing continuous responses into quantal 
